COMMUNIQUÉS West-GlobeNewswire

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
19/11/2024
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential [...]
Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer
19/11/2024
Company appoints Anil K. Sood, MD, as inaugural member Company continues to advance lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1 study, targeted for 2025 FORT LAUDERDALE, FL [...]
Raleigh Laser & Aesthetics Joins Leading Medical Associations, Elevating Standards in Non-Invasive Skincare
19/11/2024
RALEIGH, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Raleigh Laser & Aesthetics (RL&A), a premier provider of non-invasive skincare and laser treatments in North Carolina, proudly announces its membership in two [...]
TowerBrook and CD&R Complete Acquisition of R1 RCM
19/11/2024
R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today [...]
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
19/11/2024
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development Monrovia, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne [...]
Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth
19/11/2024
GAITHERSBURG, Md., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc ., a privately held, clinical-stage biotechnology company, announces the appointment of Mark Avagliano as Chief Business Officer. The news [...]
LogicMark Launches Revolutionary Medical Alert Device, Freedom Alert Max, Offering Cellular Communication Technology and 24/7 Assistance
19/11/2024
The Freedom Alert Max empowers seniors through proprietary, 4G LTE mobile technology as the first fall detection device with emergency video for caregivers, regular over-the-air feature updates, and geofencing for [...]
Dror Ortho-Design Introduces ZSmile: A Revolution in Eco-Friendly Orthodontics
19/11/2024
JERUSALEM, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (“Dror” or the “Company”) (OTC PINK: DROR), an AI-based orthodontic platform company, has developed ZSmile , an innovative solution that corrects [...]
Stride Autism Centers Appoints Emily Patrizi as Chief Operating Officer
19/11/2024
Leading Company Focused on ABA Therapy for Preschool Children with Autism Expands Leadership Team CHICAGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of Applied Behavior Analysis (ABA) [...]
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings
19/11/2024
BLOC fosters and promotes the professional advancement of leaders of color in the life sciences space via curated networking, mentorship and education. SAN FRANCISCO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Biopharma Leaders [...]
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
19/11/2024
NIH-funded Phase 2-3 ALS Expanded Access study expands reach of MediciNova’s ongoing COMBAT-ALS trial and provides illustration of Company’s development strategy LA JOLLA, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- [...]
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
19/11/2024
Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life science company focused on developing platform treatments [...]
Relmada Therapeutics to Present at Jefferies London Healthcare Conference
19/11/2024
Conference being held November 19-21, 2024 CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a late-stage biotechnology company addressing [...]
Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia's First Cardiac Gene Therapy Trial for Heart Failure
19/11/2024
Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for heart failure, with Singapore being the first and only site [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
19/11/2024
Bagsværd, Denmark, 19 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative Advances in Schizophrenia Treatment
19/11/2024
Turner, a seasoned biotechnology executive, was formerly CEO of Carmot Therapeutics, which was acquired by Roche in 2024 for $2.7 billion LB Pharma’s lead asset, LB-102, is a patent protected blood-brain barrier- [...]
Allogene Therapeutics Announces Participation in December Investor Conferences
19/11/2024
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for [...]
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
19/11/2024
Award recognizes Lisata’s data-driven approach and innovative therapies designed to address the unmet medical needs of patients with advanced solid tumors Annual BioTech Breakthrough Award is devoted to honoring [...]
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
19/11/2024
Research at the prestigious Semmelweis University, Budapest, Hungary has led the way in achieving government coverage in Hungary with a code for exoskeleton training that expands access to additional spinal cord injury [...]

Pages